申请人:——
公开号:US20030181496A1
公开(公告)日:2003-09-25
Pyrrole derivatives represented by the following formula:
1
wherein Ring Z is an optionally substituted pyrrole ring, etc.; W
2
is —CO—, —SO
2
—, an optionally substituted C
1
-C
4
alkylene, etc.; Ar
2
is an optionally substituted aryl, etc.; W
2
and Ar
1
mean the following (1) and (2):
(1) W
1
is an optionally substituted C
1
-C
4
alkylene, etc.; Ar
1
is an optionally substituted bicyclic heteroaryl having 1 to 4 nitrogen atoms as ring-forming atoms:
(2) W
1
is an optionally substituted C
2
-C
5
alkylene, an optionally substituted C
2
-C
5
alkenylene, etc.; and Ar
1
is an aryl or monocyclic heteroaryl, which are substituted by carboxyl, an alkoxycarbonyl, etc. at the ortho- or meta-position thereof with respect to the binding position of W
1
,
or a pharmaceutically acceptable salt thereof
These compounds are useful as medicaments such as a fibrosis inhibitor for organs or tissues.
以下是用中文翻译的结果:
由以下公式表示的吡咯衍生物:
其中环Z是可选择取代的吡咯环等;W
2
是—CO—,—SO
2
—,可选择取代的C
1
-C
4
烷基等;Ar
2
是可选择取代的芳基等;W
2
和Ar
1
表示如下(1)和(2):
(1)W
1
是可选择取代的C
1
-C
4
烷基等;Ar
1
是具有1至4个氮原子作为环形成原子的可选择取代的双环杂芳基:
(2)W
1
是可选择取代的C
2
-C
5
烷基,可选择取代的C
2
-C
5
烯基等;Ar
1
是芳基或单环杂芳基,其在与W
1
的结合位置相对应的邻位或间位处被羧基,烷氧羰基等取代,
或其药学上可接受的盐
这些化合物可用作器官或组织的纤维化抑制剂等药物。